What is the best course of action for a patient with hypotension (low blood pressure) who is not responding to noradrenaline (norepinephrine) therapy, with a non-recordable blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Refractory Hypotension on Norepinephrine

When a patient on norepinephrine has non-recordable blood pressure, immediately add vasopressin 0.03-0.04 units/min as second-line therapy while ensuring adequate volume resuscitation with crystalloid boluses (minimum 30 mL/kg if not already given), and consider adding epinephrine 0.1-0.5 mcg/kg/min if hypotension persists. 1, 2

Immediate Assessment and Interventions

Verify Adequate Volume Resuscitation

  • Address hypovolemia first - give crystalloid fluid boluses (minimum 30 mL/kg) if not already administered, as vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite attempts to raise blood pressure 1, 2
  • Use balanced crystalloids (lactated Ringer's or Plasma-Lyte) preferentially over normal saline 1
  • In severe hypotension with non-recordable BP, continue fluid resuscitation while simultaneously escalating vasopressor therapy rather than waiting for complete volume repletion 1

Confirm Blood Pressure Measurement

  • Place an arterial catheter immediately for continuous monitoring, as non-invasive measurements may be unreliable in severe shock 3, 2
  • Verify central venous access for vasopressor delivery to prevent tissue necrosis and ensure reliable drug delivery 1, 2

Assess Organ Perfusion

  • Evaluate tissue perfusion markers: mental status, urine output (target >50 mL/h), capillary refill, skin temperature, and lactate clearance 3, 1, 2
  • Consider pulmonary artery catheterization in patients refractory to pharmacological treatment to characterize hemodynamic pattern and identify inadequate left ventricular filling pressure 3

Vasopressor Escalation Algorithm

Add Vasopressin as Second-Line Agent

  • When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, add vasopressin 0.03-0.04 units/min rather than continuing to escalate norepinephrine alone 1, 2
  • Do not increase vasopressin above 0.03-0.04 units/min, reserving higher doses for salvage therapy only 1

Add Epinephrine if Needed

  • If hypotension persists despite norepinephrine plus vasopressin, add epinephrine 0.1-0.5 mcg/kg/min as a third agent 1, 2
  • Epinephrine may be particularly useful if there is evidence of myocardial dysfunction 2

Consider Inotropic Support

  • Add dobutamine up to 20 mcg/kg/min if persistent hypoperfusion exists despite adequate vasopressors, particularly with evidence of myocardial dysfunction 1, 2
  • Start dobutamine at 2.5 mcg/kg/min, doubling the dose every 15 minutes according to response, with titration usually limited by excessive tachycardia, arrhythmias, or ischemia 1

Target Blood Pressure Goals

  • Target mean arterial pressure (MAP) of 65 mmHg for most patients 1, 2
  • For patients with chronic hypertension, increase target MAP to ≥70 mmHg or maintain within 40 mmHg of baseline systolic pressure 2, 4
  • Titrate vasopressors based on both MAP and markers of tissue perfusion (lactate clearance, urine output, mental status, capillary refill) rather than MAP alone 1, 2

Consider Alternative Diagnoses and Mechanical Support

Rule Out Alternative Causes

  • Consider pulmonary embolism, acute mechanical problems (cardiac tamponade, tension pneumothorax), and severe valve disease (particularly aortic stenosis) in patients with persistently low blood pressure 3
  • Reassess for adequate left ventricular filling pressure using pulmonary artery catheterization if available 3

Mechanical Circulatory Support

  • Consider intra-aortic balloon pump or other mechanical circulatory support in patients without contraindications who remain in refractory shock despite maximal vasopressor therapy 3
  • Ventricular assist devices may be used as a "bridge to decision" in selected patients 3

Critical Pitfalls to Avoid

  • Never use dopamine as first-line agent - it is associated with higher mortality and more arrhythmias compared to norepinephrine 1, 2
  • Do not use phenylephrine as first-line therapy - it may raise blood pressure while worsening tissue perfusion and cardiac output 1, 2
  • Avoid low-dose dopamine for "renal protection" - it provides no benefit and is strongly discouraged 1, 2
  • Do not rely on blood pressure numbers alone - assess organ perfusion markers to guide therapy 3, 1, 2
  • Never delay mechanical ventilation if there is worsening hypoxemia, failing respiratory effort, or increasing confusion 3

References

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vasopressor Management in Critical Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The critical care literature 2020.

The American journal of emergency medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.